Home > Boards > US OTC > Delisted > Endologix Inc. (fka ELGXQ)

8:18 AM Endologix (ELGX) reports preliminary unaudited sales

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
johnsyn Member Profile
 
Followed By 65
Posts 16,392
Boards Moderated 2
Alias Born 02/14/11
160x600 placeholder
johnsyn   Monday, 07/01/13 03:14:44 PM
Re: None
Post # of 66 
8:18 AM Endologix (ELGX) reports preliminary unaudited sales for Q2 of ~$34M (+33% Y/Y) and raises FY13 revenue guidance to $128-134M. The company now projects a wider net loss than previously expected however and also says it is temporarily suspending enrollment in its Ventana U.S. IDE clinical trial.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences